Immune Globulin Intravenous (Human), 10% Solution
161003
Phase 3 mab terminated
Quick answer
Immune Globulin Intravenous (Human), 10% Solution for Alzheimer´s Disease is a Phase 3 program (mab) at Takeda Pharmaceuticals International AG with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Takeda Pharmaceuticals International AG
- Indication
- Alzheimer´s Disease
- Phase
- Phase 3
- Modality
- mab
- Status
- terminated